Identification and validation of cardiac nonconserved human-specific enhancers
Congenital heart disease(CHD)is one of the most common causes of neonatal mortality.The worldwide morbidity of CHD is 9.410‰,while the proportion of CHD patients who are re-ported to carry mutations in coding regions is<50%.1,2 En-hancers play an important role in the spatio-temporal expression of target genes,and a lot of related variations are associated with CHD.
identification、cardiac、enhancers、human-specific、nonconserved、validation
10
G40-03;TP183;X51
2023-05-26(万方平台首次上网日期,不代表论文的发表时间)
共3页
55-57